329 related articles for article (PubMed ID: 16150720)
1. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
4. Generating tolerogenic dendritic cells with neuropeptides.
Delgado M
Hum Immunol; 2009 May; 70(5):300-7. PubMed ID: 19405171
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3787-94. PubMed ID: 16418327
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
Carreño LJ; Riedel CA; Kalergis AM
Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
[TBL] [Abstract][Full Text] [Related]
8. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
Delgado M; Gonzalez-Rey E; Ganea D
Ann N Y Acad Sci; 2006 Jul; 1070():233-8. PubMed ID: 16888172
[TBL] [Abstract][Full Text] [Related]
10. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
Delgado M; Gonzalez-Rey E; Ganea D
J Immunol; 2005 Dec; 175(11):7311-24. PubMed ID: 16301637
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells.
Benkhoucha M; Molnarfi N; Dunand-Sauthier I; Merkler D; Schneiter G; Bruscoli S; Riccardi C; Tabata Y; Funakoshi H; Nakamura T; Reith W; Santiago-Raber ML; Lalive PH
J Immunol; 2014 Sep; 193(6):2743-52. PubMed ID: 25114100
[TBL] [Abstract][Full Text] [Related]
12. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
Chorny A; Gonzalez-Rey E; Delgado M
Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
14. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells for autoimmune disease and transplantation.
Thomson AW; Robbins PD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide-induced tolerogenic dendritic cells attenuated arthritis in experimental collagen-induced arthritic mice.
Wu H; Shen J; Liu L; Lu X; Xue J
Int J Rheum Dis; 2019 Jul; 22(7):1255-1262. PubMed ID: 31062502
[TBL] [Abstract][Full Text] [Related]
17. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
18. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
19. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.
Fernandez-Martin A; Gonzalez-Rey E; Chorny A; Ganea D; Delgado M
Eur J Immunol; 2006 Feb; 36(2):318-26. PubMed ID: 16402407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
